Chronic liver disease poses a growing global health burden, driven in large part by metabolic risk factors and viral hepatitis. Fibrosis stage is the principal ...
Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO-a certified algorithm ...
Non-alcoholic fatty liver disease (NAFLD) affects roughly a quarter of adults worldwide and is closely linked to obesity, type 2 diabetes and other cardiometabolic risk factors. Primary care ...
Focused ultrasound creates precise mechanical cavitation that liquefies tumor tissue while sparing adjacent parenchyma, avoiding thermal sink effects and reducing risk near major vessels and bile ...
Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO-a certified algorithm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results